Clinical Trial Details

Trial ID: L0802
Source ID: CTRI/2017/12/010997
Associated Drug: VSL#3
Title: The Effect of Probiotic VSL#3 and Lifestyle Intervention in Obese Children with Non Alcoholic Fatty Liver Disease(NAFLD):A Randomized Clinical Trial - NA
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: --
Interventions: Intervention1: VSL#3 probiotic <br>live freeze dried lactic acid bacteria and bifidobacteria capsules: 4 capsules of VSL#3 probiotic less than 10yrs and 8 capsules above 10 yrs for 4 months<br>Control Intervention1: Placebo capsules containing corn starch
Outcome Measures: The primary outcome is the evaluation of beneficial effect of probiotic VSl#3 for the treatment of fatty liver disease in obese childrenTimepoint: 4 months interventionAssessment of Probiotic VSL#3 for controlling the biochemical parameters LFT Lipid profile etc Hunger hormone leptin ghrelinTimepoint: 4 months intervention
Sponsor/Collaborators: Babe Ke Ayurvedic Hospital VPO Daudhar
Gender: --
Age: nannan
Phases: Phase 1
Enrollment: 100
Study Type: Interventional
Study Designs: Randomized, Parallel Group, Placebo Controlled Trial<br> Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Participant and Investigator Blinded
Start Date: 27/12/2017
Completion Date: 07/01/2019
Results First Posted: --
Last Update Posted: 24 November 2021
Locations: India
URL: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=19361